Clinical acceptability of monophasic gestodene

B Düsterberg, K Brill - American journal of obstetrics and gynecology, 1990 - Elsevier
The monophasic low-dose contraceptive containing 30 μg of ethinyl estradiol and 75 μg of
gestodene has been tested in numerous clinical studies to determine contraceptive …
被引用次数：20 相关文章 所有 6 个版本

[引用][C] Three years clinical experience with a new low-dose oral contraceptive containing 20 mg ethinyl estradiol and 75 mg gestodene: Efficacy, cycle control and …

B Düsterberg, H Ellman, U Müller, E Rowe, B Muhe - The New Option in Low-dose …, 1995
被引用次数：4 相关文章

Efficacy, cycle control and side-effects of two monophasic combination oral contraceptives: Gestodene/ethinylestradiol and norgestimate/ethinylestradiol

P Affinito, M Monterubbianesi, M Primizia… - Gynecological …, 1993 - Taylor & Francis
Two monophasic oral contraceptives containing gestodene (GTD, 15 μg) and
ethinylestradiol (EE, 30 μg) or norgestimate (NGS, 250 μg) and EE (35 μg) were compared …
被引用次数：15 相关文章 所有 5 个版本

A multicenter clinical evaluation of a new monophasic combination: Minulet (gestodene and ethinyl estradiol).

RP de Andrade - International Journal of Fertility, 1989 - europepmc.org
The safety and efficacy of a low-dose monophasic oral contraceptive (OC) containing a new
progestogen, gestodene (GTD), combined with ethinyl estradiol (EE) is being investigated in …
被引用次数：14 相关文章 所有 2 个版本

Triphasic combination of ethinyl estradiol and gestodene long-term clinical trial

F Weber-Diehl, R Unger, U Lachnit - Contraception, 1992 - Elsevier
A triphasic oral contraceptive containing ethinyl estradiol and gestodene was used by 1933
women for up to 36 cycles in order to evaluate contraceptive efficacy, general tolerance and …
被引用次数：40 相关文章 所有 6 个版本
[PDF] academia.edu

Comparative study on the acceptability of two modern monophasic oral contraceptive preparations: 30 μg ethinyl estradiol combined with 150 μg desogestrel or 75 μg …

L Zichella, C Sbrignadello, A Tomassini… - Advances in …, 1999 - Springer
Cycle control and tolerability of two monophasic oral contraceptive pills containing 30 μg
ethinyl estradiol (EE) with either 150 μg desogestrel (DSG) or 75 μg gestodene (GSD) were …
被引用次数：12 相关文章 所有 13 个版本

The safety and contraceptive efficacy of a 24-day low-dose oral contraceptive regimen containing gestodene 60 µg and ethinylestradiol 15 µg

Gestodene Study Group 322 - The European Journal of …, 1999 - Taylor & Francis
Objectives: The safety and contraceptive efficacy of a new 24-day regimen of an oral
contraceptive combination containing gestodene (GTD) 60 µg and ethinylestradiol (EE) 15 …
被引用次数：12 相关文章

Clinical and metabolic effects of gestodene and levonorgestrel.

T Rabe, B Runnebaum, M Kohlmeier… - … journal of fertility, 1987 - europepmc.org
The new low-dose combination oral contraceptive (OC) containing 75 micrograms of the
new progestogen gestodene (GTD) plus 30 micrograms ethinyl estradiol (EE) was clinically …
被引用次数：34 相关文章 所有 2 个版本

Clinical experience with a modern low-dose gestodene-containing oral contraceptive in adolescents

K Brill, J Schnitker, M Albring - Advances in contraception, 1994 - Springer
This clinical investigation of a low-dose, monophasic gestodene-containing oral
contraceptive (75 μg gestodene/30 μg ethinylestradiol), investigated contraceptive efficacy …
被引用次数：16 相关文章 所有 6 个版本
[PDF] ufba.br

Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 μg and …

IC Barbosa, C Isaia Filho, D Faggion Jr, EC Baracat - Contraception, 2006 - Elsevier
OBJECTIVE: A prospective, open-label, noncomparative, multicenter study was carried out
in 163 women aged 18–39 (mean 25±5 years), who used an ultra-low-dose oral …
被引用次数：42 相关文章 所有 13 个版本